---
category: news
title: "Stephen Elledge's Har­vard lab takes $17M to birth Im­muneID, a high-through­put an­ti­body start­up"
excerpt: "Lea Hachigian, a principal at the Longwood Fund, recalls working with Harvard professor Stephen Elledge three years ago on the launch of TCR-focused TScan Therapeutics. Elledge initially set out to screen antigen-TCR matches in a faster,"
publishedDateTime: 2021-02-17T16:07:00Z
originalUrl: "https://endpts.com/stephen-elledges-harvard-lab-takes-17m-to-birth-immuneid-a-high-throughput-antibody-startup/"
webUrl: "https://endpts.com/stephen-elledges-harvard-lab-takes-17m-to-birth-immuneid-a-high-throughput-antibody-startup/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - AI

secured: "RBaYw6SdqM4i7Oorf03xcM6WgklgQONAee2vfnte+5JgtViqMOMMtsxHGB5DTRo3KCbr3iWnYXgakmB+Yj/1tXXyWhMHZJDUm7zXT6Jpj+jfApaow9HKqKNiSS4udMNEGUMY9O4QHbg5WG/9hZVzFjsEjGv12zoyzmHDeyfjCacxuTrSeGt7Qj8JHXIk7sVnEMUtC6W+RGid0W3d+f4VA0N2Tr2pEJMRHczubcwn9Ba7Qq921HdXs203LujSOl71foQdGoXAHPHwhTjkaVUmDf8BVpHMLNMe5FWhK2h9Wcnxb/qtNpzF+an/mXd3jmhpsOy3DG4weYdlqH98p00oOG89GQtbtIq6mbotacjneZ84LYzXuiT0aQlf/fLQTWULqeNTtAnefzwZKxDycYU0ralLwQ+PkHtlMGbl1LV1xcINR1hMQ91QrMZFjzhrgdlKGaX9rrjb50K15W78M375qNCOYEZtz3wHpPDVbziIYvYdH9AB9rGDJw4aZYdgBE9LKHbUtqrEd9gp7n2KYBCo1g==;8H2OlHJd3jhuqCDboDH5tw=="
---

